CochlearMEX:COHN 75 FCF Margin % is 8.27% as of Dec. 2025, which is 38% below its 10-year median of 13.32. GuruFocus rates MEX:COHN with a GF Score™ of 75/100 and a GF Value™ of MXN6,298.88. The stock has 2 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Cochlear ranks better than 66.5% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Cochlear's Free Cash Flow for the
six
months ended in Dec. 2025 was MXN1,155 Mil. Cochlear's Revenue for the
six
months ended in Dec. 2025 was MXN13,964 Mil. Therefore, Cochlear's FCF Margin % for the quarter that ended in Dec. 2025 was 8.27%.
The historical rank and industry rank for Cochlear's FCF Margin % or its related term are showing as below:
MEX:COHN'
s FCF Margin % Range Over the Past 10 Years
Min: -21.83 Med: 13.32 Max: 18.16
Current: 7.06
During the past 13 years, the highest FCF Margin % of Cochlear was 18.16%. The lowest was -21.83%. And the median was 13.32%.
MEX:COHN's FCF Margin % is ranked better than 66.5% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.03
vs MEX:COHN: 7.06
Cochlear FCF Margin % Related Terms
Cochlear FCF Margin % Historical Data
* Premium members only.
The historical data trend for Cochlear's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:COHN vs ABT, SYK, MDT: FCF Margin % Comparison
For the Medical Devices subindustry, Cochlear's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cochlear FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Cochlear's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Cochlear's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cochlear (MEX:COHN) has a FCF Margin % of 8.27% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Cochlear and its competitors. This is 38% below median its historical median of 13.32. According to the industry distribution chart, Cochlear ranks #273 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 33.5%.
Is Cochlear's FCF Margin % too high?
Cochlear's current FCF Margin % of 8.27% is 38% below median its 10-year median of 13.32. Based on the distribution chart, Cochlear ranks #273 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Cochlear has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does Cochlear's FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Cochlear ranks #273 out of 815 companies for FCF Margin %. This puts Cochlear in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Cochlear and its competitors. Cochlear's current FCF Margin % is 8.27%, which is 38% below median its own 10-year median of 13.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cochlear stock overvalued right now?
Cochlear (MEX:COHN) has a current FCF Margin % of 8.27%. The stock's GF Value™ is MXN6,298.88, compared to a current price of MXN2,391.38 — trading 62% below its estimated fair value. The current FCF Margin % is 8.27%, which is 38% below median its 10-year median of 13.32. Cochlear's overall GF Score™ is 75/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Cochlear (MEX:COHN), the current FCF Margin % is 8.27% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cochlear (MEX:COHN) Overvalued in 2026?
Based on GuruFocus' analysis, Cochlear stock appears to be undervalued.
The current stock price of MXN2,391.38 is trading 62% below its estimated GF Value™ of MXN6,298.88.
Key valuation signals for MEX:COHN:
FCF Margin %: 8.27% (38% below median its 10-year median of 13.32)
GF Value™: MXN6,298.88 vs. price of MXN2,391.38 (62% below fair value)
No single metric tells the full story. See the MEX:COHN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cochlear is the leading cochlear implant device manufacturer, with around 60% global market share. Developed markets contribute 80% of group revenue, where cochlear implants are the standard of care for children with severe-to-profound hearing loss. The company also actively targets the growing cohort of seniors in developed markets. Tender-oriented emerging markets contribute the remaining 20% of group revenue. Main products include cochlear implants, bone-anchored hearing aids, and associated sound processors. In fiscal 2025, 49% of revenue came from the Americas, 34% from Europe, the Middle East, and Africa, and 18% from the Asia-Pacific segment.
75GF Score
Get the complete analysis for MEX:COHN
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:COHN has been successfully added to your 
